Status: Recruiting
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
This study plans to learn more about the safety and tolerability of psychedelic administration (psilocybin) in healthy older adults ages 65-85.
Participants needed: 40
Trial details
Phase: Phase 1Age: 65-85Biological sex: AllType: InterventionalSponsor: University of Colorado, DenverUpdated: Jun 30, 2026Locations: 6
Eligibility criteria
Aged 65-85 years & be male, female, or non-binary [+3]
Unstable medical condition [+12]